Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 38

1.

Twenty-four hour pharmacokinetic relationships for intravenous vancomycin and novel urinary biomarkers of acute kidney injury in a rat model.

Avedissian SN, Pais GM, O'Donnell JN, Lodise TP, Liu J, Prozialeck WC, Joshi MD, Lamar PC, Becher L, Gulati A, Hope W, Scheetz MH.

J Antimicrob Chemother. 2019 Aug 1;74(8):2326-2334. doi: 10.1093/jac/dkz167.

PMID:
31065686
2.

Comparative Performance of Urinary Biomarkers for Vancomycin-Induced Kidney Injury According to Timeline of Injury.

Pais GM, Avedissian SN, O'Donnell JN, Rhodes NJ, Lodise TP, Prozialeck WC, Lamar PC, Cluff C, Gulati A, Fitzgerald JC, Downes KJ, Zuppa AF, Scheetz MH.

Antimicrob Agents Chemother. 2019 Jun 24;63(7). pii: e00079-19. doi: 10.1128/AAC.00079-19. Print 2019 Jul.

PMID:
30988153
3.

Optimal treatment of MSSA bacteraemias: a meta-analysis of cefazolin versus antistaphylococcal penicillins.

Bidell MR, Patel N, O'Donnell JN.

J Antimicrob Chemother. 2018 Oct 1;73(10):2643-2651. doi: 10.1093/jac/dky259.

PMID:
30085140
4.

Prevalence of a Cefazolin Inoculum Effect Associated with blaZ Gene Types among Methicillin-Susceptible Staphylococcus aureus Isolates from Four Major Medical Centers in Chicago.

Wang SK, Gilchrist A, Loukitcheva A, Plotkin BJ, Sigar IM, Gross AE, O'Donnell JN, Pettit N, Buros A, O'Driscoll T, Rhodes NJ, Bethel C, Segreti J, Charnot-Katsikas A, Singh K, Scheetz MH.

Antimicrob Agents Chemother. 2018 Jul 27;62(8). pii: e00382-18. doi: 10.1128/AAC.00382-18. Print 2018 Aug.

5.

Carbapenems vs. alternative β-lactams for the treatment of nosocomial pneumonia: A systematic review and meta-analysis.

O'Donnell JN, Rhodes NJ, Lopez J, Jett R, Scheetz MH.

Int J Antimicrob Agents. 2018 Oct;52(4):451-458. doi: 10.1016/j.ijantimicag.2018.04.011. Epub 2018 Apr 14. Review.

PMID:
29665442
6.

Resistance Trends and Treatment Options in Gram-Negative Ventilator-Associated Pneumonia.

Rhodes NJ, Cruce CE, O'Donnell JN, Wunderink RG, Hauser AR.

Curr Infect Dis Rep. 2018 Mar 6;20(2):3. doi: 10.1007/s11908-018-0609-x. Review.

7.

Correlation between hospital-level antibiotic consumption and incident health care facility-onset Clostridium difficile infection.

Crew PE, Rhodes NJ, O'Donnell JN, Miglis C, Gilbert EM, Zembower TR, Qi C, Silkaitis C, Sutton SH, Scheetz MH.

Am J Infect Control. 2018 Mar;46(3):270-275. doi: 10.1016/j.ajic.2017.09.015. Epub 2017 Nov 21.

PMID:
29169938
8.

Prolonged Infusion Piperacillin-Tazobactam Decreases Mortality and Improves Outcomes in Severely Ill Patients: Results of a Systematic Review and Meta-Analysis.

Rhodes NJ, Liu J, O'Donnell JN, Dulhunty JM, Abdul-Aziz MH, Berko PY, Nadler B, Lipman J, Roberts JA.

Crit Care Med. 2018 Feb;46(2):236-243. doi: 10.1097/CCM.0000000000002836.

PMID:
29116995
9.

24-Hour Pharmacokinetic Relationships for Vancomycin and Novel Urinary Biomarkers of Acute Kidney Injury.

O'Donnell JN, Rhodes NJ, Lodise TP, Prozialeck WC, Miglis CM, Joshi MD, Venkatesan N, Pais G, Cluff C, Lamar PC, Briyal S, Day JZ, Gulati A, Scheetz MH.

Antimicrob Agents Chemother. 2017 Oct 24;61(11). pii: e00416-17. doi: 10.1128/AAC.00416-17. Print 2017 Nov.

10.

Dose, duration, and animal sex predict vancomycin-associated acute kidney injury in preclinical studies.

O'Donnell JN, Rhodes NJ, Miglis CM, Catovic L, Liu J, Cluff C, Pais G, Avedissian S, Joshi MD, Griffin B, Prozialeck W, Gulati A, Lodise TP, Scheetz MH.

Int J Antimicrob Agents. 2018 Feb;51(2):239-243. doi: 10.1016/j.ijantimicag.2017.08.012. Epub 2017 Aug 10. Review.

11.

High-Performance Liquid Chromatography Method for Rich Pharmacokinetic Sampling Schemes in Translational Rat Toxicity Models With Vancomycin.

Joshi MD, O'Donnell JN, Venkatesan N, Chang J, Nguyen H, Rhodes NJ, Pais G, Chapman RL, Griffin B, Scheetz MH.

Clin Transl Sci. 2017 Nov;10(6):496-502. doi: 10.1111/cts.12484. Epub 2017 Jul 4.

12.

Population pharmacokinetics of cefepime in febrile neutropenia: implications for dose-dependent susceptibility and contemporary dosing regimens.

Rhodes NJ, Grove ME, Kiel PJ, O'Donnell JN, Whited LK, Rose DT, Jones DR, Scheetz MH.

Int J Antimicrob Agents. 2017 Sep;50(3):482-486. doi: 10.1016/j.ijantimicag.2017.04.008. Epub 2017 Jun 28.

PMID:
28668694
13.

Correction for Rhodes et al., Evaluation of Vancomycin Exposures Associated with Elevations in Novel Urinary Biomarkers of Acute Kidney Injury in Vancomycin-Treated Rats.

Rhodes NJ, Prozialeck WC, Lodise TP, Venkatesan N, O'Donnell JN, Pais G, Cluff C, Lamar PC, Neely MN, Gulati A, Scheetz MH.

Antimicrob Agents Chemother. 2017 Mar 24;61(4). pii: e00185-17. doi: 10.1128/AAC.00185-17. Print 2017 Apr. No abstract available.

14.

Eight unexpected cases of vancomycin associated acute kidney injury with contemporary dosing.

O'Donnell JN, Ghossein C, Rhodes NJ, Peng J, Lertharakul T, Pham CK, Scheetz MH.

J Infect Chemother. 2017 May;23(5):326-332. doi: 10.1016/j.jiac.2016.12.011. Epub 2017 Jan 18.

15.

Pharmacokinetics of Cefepime in Patients with Cancer and Febrile Neutropenia in the Setting of Hematologic Malignancies or Hematopoeitic Cell Transplantation.

Whited L, Grove M, Rose D, Rhodes NJ, Scheetz MH, O'Donnell JN, Neeb J, Thoele K, Jones DR, Lowe C, Moore D, Kiel PJ.

Pharmacotherapy. 2016 Sep;36(9):1003-10. doi: 10.1002/phar.1807. Epub 2016 Sep 6.

PMID:
27496678
16.

Evaluation of Vancomycin Exposures Associated with Elevations in Novel Urinary Biomarkers of Acute Kidney Injury in Vancomycin-Treated Rats.

Rhodes NJ, Prozialeck WC, Lodise TP, Venkatesan N, O'Donnell JN, Pais G, Cluff C, Lamar PC, Neely MN, Gulati A, Scheetz MH.

Antimicrob Agents Chemother. 2016 Sep 23;60(10):5742-51. doi: 10.1128/AAC.00591-16. Print 2016 Oct. Erratum in: Antimicrob Agents Chemother. 2017 Mar 24;61(4):.

17.

Pharmacokinetics of centhaquin citrate in a dog model.

O'Donnell JN, O'Donnell EP, Kumar EJ, Lavhale MS, Andurkar SV, Gulati A, Scheetz MH.

J Pharm Pharmacol. 2016 Jun;68(6):803-9. doi: 10.1111/jphp.12554. Epub 2016 Apr 25.

PMID:
27109141
18.

Investigating the Extremes of Antibiotic Use with an Epidemiologic Framework.

Scheetz MH, Crew PE, Miglis C, Gilbert EM, Sutton SH, O'Donnell JN, Postelnick M, Zembower T, Rhodes NJ.

Antimicrob Agents Chemother. 2016 May 23;60(6):3265-9. doi: 10.1128/AAC.00572-16. Print 2016 Jun.

19.

Carbapenem susceptibility breakpoints, clinical implications with the moving target.

O'Donnell JN, Miglis CM, Lee JY, Tuvell M, Lertharakul T, Scheetz MH.

Expert Rev Anti Infect Ther. 2016;14(4):389-401. doi: 10.1586/14787210.2016.1159131. Review.

PMID:
26918486
20.

Visual and absorbance analyses of admixtures containing vancomycin and piperacillin-tazobactam at commonly used concentrations.

O'Donnell JN, Venkatesan N, Manek M, Rhodes NJ, Scheetz MH.

Am J Health Syst Pharm. 2016 Feb 15;73(4):241-6. doi: 10.2146/ajhp150170.

PMID:
26843502
21.

Pharmacokinetics of centhaquin citrate in a rat model.

O'Donnell JN, Gulati A, Lavhale MS, Sharma SS, Patel AJ, Rhodes NJ, Scheetz MH.

J Pharm Pharmacol. 2016 Jan;68(1):56-62. doi: 10.1111/jphp.12498. Epub 2016 Jan 4.

PMID:
26725913
22.

Outcomes and Risk Factors for Mortality among Patients Treated with Carbapenems for Klebsiella spp. Bacteremia.

Biehle LR, Cottreau JM, Thompson DJ, Filipek RL, O'Donnell JN, Lasco TM, Mahoney MV, Hirsch EB.

PLoS One. 2015 Nov 30;10(11):e0143845. doi: 10.1371/journal.pone.0143845. eCollection 2015.

23.

Tree-Based Models for Predicting Mortality in Gram-Negative Bacteremia: Avoid Putting the CART before the Horse.

Rhodes NJ, O'Donnell JN, Lizza BD, McLaughlin MM, Esterly JS, Scheetz MH.

Antimicrob Agents Chemother. 2015 Nov 23;60(2):838-44. doi: 10.1128/AAC.01564-15. Print 2016 Feb.

24.

Ultra-small-angle X-ray scattering-X-ray photon correlation spectroscopy studies of incipient structural changes in amorphous calcium phosphate-based dental composites.

Zhang F, Allen AJ, Levine LE, Espinal L, Antonucci JM, Skrtic D, O'Donnell JN, Ilavsky J.

J Biomed Mater Res A. 2012 May;100(5):1293-306. doi: 10.1002/jbm.a.34018. Epub 2012 Feb 28.

25.

Leachability and Cytotoxicity of an Experimental Polymeric ACP Composite.

Antonucci JM, Davis CH, Sun J, O'Donnell JN, Skrtic D.

PMSE Preprints. 2011 Spring;104:300-302. No abstract available.

26.
27.

Selected physicochemical properties of the experimental endodontic sealer.

Johns JI, O'Donnell JN, Skrtic D.

J Mater Sci Mater Med. 2010 Feb;21(2):797-805. doi: 10.1007/s10856-009-3873-3. Epub 2009 Sep 19.

28.

AMORPHOUS CALCIUM PHOSPHATE COMPOSITES AND THEIR EFFECT ON COMPOSITE-ADHESIVE-DENTIN BONDING.

Antonucci JM, O'Donnell JN, Schumacher GE, Skrtic D.

J Adhes Sci Technol. 2009 Jan 1;23(7):1133-1147.

29.

Polymerization stress development in dental composites: Effect of cavity design factor.

Antonucci JM, Giuseppetti AA, O'Donnell JN, Schumacher GE, Skrtic D.

Materials (Basel). 2009 Mar;2(1):169-180.

30.

In vitro remineralization of enamel by polymeric amorphous calcium phosphate composite: quantitative microradiographic study.

Langhorst SE, O'Donnell JN, Skrtic D.

Dent Mater. 2009 Jul;25(7):884-91. doi: 10.1016/j.dental.2009.01.094. Epub 2009 Feb 11.

31.

Structure-Composition-Property Relationships in Polymeric Amorphous Calcium Phosphate-Based Dental Composites.

O'Donnell JN, Schumacher GE, Antonucci JM, Skrtic D.

Materials (Basel). 2009;2(4):1929-1959.

32.

Adhesion of amorphous calcium phosphate composites bonded to dentin: a study in failure modality.

O'Donnell JN, Schumacher GE, Antonucci JM, Skrtic D.

J Biomed Mater Res B Appl Biomater. 2009 Jul;90(1):238-49. doi: 10.1002/jbm.b.31278.

33.

Amorphous calcium phosphate composites with improved mechanical properties.

O'Donnell JN, Antonucci JM, Skrtic D.

J Bioact Compat Polym. 2006;21(3):169-184.

34.

Light-cured dimethacrylate-based resins and their composites: comparative study of mechanical strength, water sorption and ion release.

O'Donnell JN, Langhorst SE, Fow MD, Antonucci JM, Skrtic D.

J Bioact Compat Polym. 2008;23(3):207-226.

35.

EFFECTS OF FILLER, INITIATOR AND CAVITY DESIGN FACTOR ON POLYMERIZATION STRESS DEVELOPED IN DENTAL COMPOSITES.

Antonucci JM, Giuseppetti AA, O'Donnell JN, Schumacher GE, Skrtic D.

Polymer Prepr. 2008;49(2):414-415. No abstract available.

36.
37.
38.

POLYMERIZATION SHRINKAGE AND STRESS DEVELOPMENT IN BIOACTIVE URETHANE ACRYLIC RESIN COMPOSITES.

Antonucci JM, Icenogle TB, Regnault WF, Liu DW, O'Donnell JN, Skrtic D.

Polymer Prepr. 2006 Jan 1;47(1):498-499. No abstract available.

Supplemental Content

Loading ...
Support Center